Lately, it was found that an increased abundance of beneficial bacteria, such as Lactobacillus and Christenellaceae, enhanced a protective production of IL-22, which exerted particularly anti-inflammatory properties in NASH patients [45]. Here, IL22 is linked to metabolic dysfunction-associated steatohepatitis.